Research

CRUNCHFISH: Detailing the eight revenue opportunities ahead

Analys, Research

While the Q3’24 report did not contain any particular surprises in terms of financials, it did provide details on the eight revenue...

Read More

NANEXA AB: Positive clinical data balanced by strategic uncertainty about NEX-22 roadmap

Analys, Research

Nanexa presented strong validation of its PharmaShell technology during the first half of 2025, with Phase I data showing once-monthly...

Read More

PROLIGHT: Fully subscribed rights issue strengthens Psyros case ahead of commercial partnerships

Analys, Research

Prolight announced that its rights issue was fully subscribed, eliminating near-term financing risk and securing the capital needed to...

Read More

CRUNCHFISH: Breakthrough integration sets stage for commercial expansion

Analys, Research

Crunchfish’s new go-to-market strategy for offline payments, splitting the solution into terminals for payment networks and wallets for...

Read More

For new research on growth stocks, sign up to our newsletter